To Örebro University

oru.seÖrebro University Publications
Change search
Link to record
Permanent link

Direct link
Savilampi, Johanna
Publications (10 of 25) Show all publications
Liljedahl Prytz, K., Kryss, E., Oxelbark, J., Källman, J., Nilsson, K. F., Sundqvist, M. & Savilampi, J. (2026). β-Lactam concentrations monitored in the early phase of community-acquired sepsis in the intensive care unit. Journal of Antimicrobial Chemotherapy, 81(1), Article ID dkaf401.
Open this publication in new window or tab >>β-Lactam concentrations monitored in the early phase of community-acquired sepsis in the intensive care unit
Show others...
2026 (English)In: Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, E-ISSN 1460-2091, Vol. 81, no 1, article id dkaf401Article in journal (Refereed) Published
Abstract [en]

OBJECTIVES: Optimal antibiotic treatment is important in the treatment of sepsis. However, patients with sepsis are at risk of suboptimal antibiotic concentrations. This study aimed to evaluate β-lactam antibiotic concentrations during the first 48 h in patients with community-acquired sepsis admitted to the ICU, and to identify variables associated with antibiotic concentrations that were too low or too high.

METHODS: This prospective, observational, single-centre study included patients aged ≥18 years with a high likelihood of infection, a SOFA score of ≥2p, planned β-lactam antibiotic treatment, and ICU admission. The exclusion criteria were ongoing antibiotic treatment and/or nosocomial infections. β-Lactam concentrations were measured up to seven times during the first 48 h. The estimated trough concentrations were divided by the predetermined MIC to generate MIC-multiples for comparison. Patients were allocated to three groups based on the MIC-multiple (MIC× < 1, 1-8 or >8).

RESULTS: Fifty patients were included, with a median of seven samples per patient (257 samples). The group with MIC-multiples of <1 (n = 16) was associated with younger age, lower Charlson comorbidity index, Simplified Acute Physiology Score 3, creatinine concentration, and need for noradrenaline. The group with MIC-multiples of >8 (n = 15) had higher creatinine and noradrenaline levels.

CONCLUSIONS: ICU patients with sepsis are at risk of either too low or too high antibiotic concentrations, and specific patient characteristics may be predictable. Therapeutic drug monitoring in combination with model-informed precision dosing may also help to optimize antibiotic dosing in the early phase of community-acquired sepsis to prevent treatment failure and toxicity.

Place, publisher, year, edition, pages
Oxford University Press, 2026
National Category
Infectious Medicine
Identifiers
urn:nbn:se:oru:diva-124644 (URN)10.1093/jac/dkaf401 (DOI)001603667400001 ()41148118 (PubMedID)
Funder
Region Örebro County, OLL-1005008Region Örebro County, OLL-996412Nyckelfonden, OLL-1001050Nyckelfonden, OLL-780321Örebro University
Available from: 2025-10-29 Created: 2025-10-29 Last updated: 2026-02-05Bibliographically approved
Bentzer, P., Lindén, A., Olsen, M. H., Lilja, G., Fisher, J., Sjövall, F., . . . Jakobsen, J. C. (2025). Protocolized REDUction of Non-Resuscitation Fluids in SEptic Shock Patients: A Protocol for the REDUSE Randomized Clinical Trial. Acta Anaesthesiologica Scandinavica, 69(7), Article ID e70095.
Open this publication in new window or tab >>Protocolized REDUction of Non-Resuscitation Fluids in SEptic Shock Patients: A Protocol for the REDUSE Randomized Clinical Trial
Show others...
2025 (English)In: Acta Anaesthesiologica Scandinavica, ISSN 0001-5172, E-ISSN 1399-6576, Vol. 69, no 7, article id e70095Article in journal (Refereed) Published
Abstract [en]

In septic shock, administration of large fluid volumes is associated with poor outcomes. Recent evidence shows that non-resuscitation fluids are the major modifiable source of fluids for patients with septic shock in intensive care units (ICUs). This clinical trial is designed to test the hypothesis that restrictive administration of non-resuscitation fluids improves outcomes compared to usual care. Adult patients admitted to ICUs with septic shock will be randomly assigned within 12 h of admission to receive protocolized restrictive administration of non-resuscitation fluids or usual care. The primary outcome is all-cause mortality at 90 days. Secondary outcomes are complications during ICU stay up to 90 days (defined as any acute kidney injury or cerebral, coronary, intestinal, or limb ischemia), mechanical ventilation free days within 90 days, and for survivors cognitive function (by the Montreal Cognitive Assessment [MOCA-BLIND]) and Health-Related Quality of Life (by the EQ Visual Analogue Scale [EQ-VAS]), both at 6 months. In addition, the climate impact of the interventions will be assessed. To detect an absolute reduction in mortality of 7.5%, with an alpha of 5% and a power of 90%, we aim to include 1850 patients. The trial is approved by the Swedish Ethical Review Authority. Results of primary and secondary clinical outcomes and the environmental outcome will be submitted for publication in a peer-reviewed journal.

Trial Registration: NCT06140147.

Place, publisher, year, edition, pages
John Wiley & Sons, 2025
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:oru:diva-122654 (URN)10.1111/aas.70095 (DOI)001535067500005 ()40671283 (PubMedID)2-s2.0-105011100273 (Scopus ID)
Funder
Swedish Research Council, 2023-00257Anna and Edwin Bergers FoundationStig och Ragna Gorthons stiftelseRegion Skåne
Note

This work was supported by the Swedish Research Counsil (2023-00257), the Anna och Edwin Bergers Foundation, the Stig and Ragna Gorthon Foundation, a Swedish government grant for clinical research within the Swedish National Health Service (ALF Grant number 86626) and a Regional Research Grant from Region Skåne, Sweden.

Available from: 2025-08-12 Created: 2025-08-12 Last updated: 2026-01-23Bibliographically approved
Cajander, P., Omari, T., Magnuson, A., Scheinin, H., Scheinin, M. & Savilampi, J. (2023). Effects of dexmedetomidine on pharyngeal swallowing and esophageal motility: A double-blind randomized cross-over study in healthy volunteers. Neurogastroenterology and Motility, 35(1), Article ID e14501.
Open this publication in new window or tab >>Effects of dexmedetomidine on pharyngeal swallowing and esophageal motility: A double-blind randomized cross-over study in healthy volunteers
Show others...
2023 (English)In: Neurogastroenterology and Motility, ISSN 1350-1925, E-ISSN 1365-2982, Vol. 35, no 1, article id e14501Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Sedative agents increase the risk of pulmonary aspiration, where an intact swallowing function is an important defense mechanism. Dexmedetomidine is an α2 -adrenoceptor agonist widely used during procedural sedation due to beneficial properties with minimal respiratory effects. The effects of dexmedetomidine on pharyngeal swallowing and esophageal motility are not known in detail.

METHODS: To determine the effects of dexmedetomidine on pharyngeal swallowing and esophageal motility, nineteen volunteers were included in this double-blinded, randomized placebo-controlled cross-over study. Study participants received target-controlled dexmedetomidine and placebo infusions. Recordings of pressure and impedance data were acquired using a manometry and impedance solid-state catheter. Data were analyzed from three bolus swallows series: baseline, during dexmedetomidine/placebo infusion at target plasma concentrations 0.6 ng ml-1 and 1.2 ng ml-1 . Subjective swallowing difficulties were also recorded.

KEY RESULTS: On pharyngeal swallowing, dexmedetomidine affected the upper esophageal sphincter with decreased pre- and post-swallow contractile pressures and an increase in residual pressure during swallow-related relaxation. On esophageal function, dexmedetomidine decreased contractile vigor of the proximal esophagus and increased velocity of the peristaltic contraction wave. Residual pressures during swallow-related esophagogastric junction (EGJ) relaxation decreased, as did basal EGJ resting pressure. The effects on the functional variables were not clearly dose-dependent, but mild subjective swallowing difficulties were more common at the higher dose level.

CONCLUSIONS AND INFERENCES: Dexmedetomidine induces effects on pharyngeal swallowing and esophageal motility, which should be considered in clinical patient management and also when a sedative agent for procedural sedation or for manometric examination is to be chosen.

Place, publisher, year, edition, pages
Wiley-Blackwell Publishing Inc., 2023
Keywords
Dexmedetomidine, esophageal motility, pulmonary aspiration, sedatives, swallowing function
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:oru:diva-102538 (URN)10.1111/nmo.14501 (DOI)000894029900001 ()36458525 (PubMedID)2-s2.0-85143893570 (Scopus ID)
Funder
Region Örebro CountyÖrebro University
Note

Funding agencies:

National Health and Medical Research Council (NHMRC) of Australia

University of Turku

Available from: 2022-12-05 Created: 2022-12-05 Last updated: 2023-04-21Bibliographically approved
Cajander, P., Omari, T., Scheinin, H., Scheinin, M. & Savilampi, J. (2023). Response to Letter to the Editor [Letter to the editor]. Neurogastroenterology and Motility, 35(8), Article ID e14616.
Open this publication in new window or tab >>Response to Letter to the Editor
Show others...
2023 (English)In: Neurogastroenterology and Motility, ISSN 1350-1925, E-ISSN 1365-2982, Vol. 35, no 8, article id e14616Article in journal, Letter (Refereed) Published
Abstract [en]

It is crucial to consider the possible influence of anesthetic agents on esophageal function testing. Dexmedetomidine has been shown to affect primary peristalsis during esophageal manometry. In the two case reports presented by Toaz et al., secondary peristalsis during FLIP panometry was also affected. This may be attributed to an alternate pharmacodynamic effect, with a transient direct α2-mediated effect on esophageal smooth muscle, associated with a high plasma concentration following bolus injection, prior to the onset of sympathetic inhibition.

Place, publisher, year, edition, pages
Wiley-Blackwell, 2023
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:oru:diva-106107 (URN)10.1111/nmo.14616 (DOI)000996505800001 ()37246925 (PubMedID)2-s2.0-85161018783 (Scopus ID)
Available from: 2023-05-30 Created: 2023-05-30 Last updated: 2023-08-11Bibliographically approved
Milton, A., Schandl, A., Larsson, I.-M., Wallin, E., Savilampi, J., Meijers, K., . . . Sackey, P. (2022). Caregiver burden and emotional wellbeing in informal caregivers to ICU survivors-A prospective cohort study. Acta Anaesthesiologica Scandinavica, 66(1), 94-102
Open this publication in new window or tab >>Caregiver burden and emotional wellbeing in informal caregivers to ICU survivors-A prospective cohort study
Show others...
2022 (English)In: Acta Anaesthesiologica Scandinavica, ISSN 0001-5172, E-ISSN 1399-6576, Vol. 66, no 1, p. 94-102Article in journal (Refereed) Published
Abstract [en]

Background: Informal caregivers to intensive care unit (ICU) survivors may develop post-intensive care syndrome family (PICS-F), including depression, anxiety and post-traumatic stress (PTS). Our primary aim was to investigate associations between caregiver burden in informal caregivers cohabiting with ICU survivors and patients' physical and psychological outcomes.

Methods: A prospective, multicentre cohort study in four ICUs in Sweden. Adults cohabiting with ICU patients included in a previous study were eligible for inclusion. Three months post-ICU, informal caregivers received questionnaires assessing caregiver burden, health-related quality of life (HRQL) and symptoms of depression, anxiety and PTS. In parallel, patients reported their three-month physical and psychological status via validated questionnaires. The primary outcome of this study was to compare caregiver burden in informal caregivers to patients with and without adverse physical and psychological outcomes 3 months post-ICU. Secondary outcomes were correlations between caregiver burden and informal caregivers' mental HRQL.

Results: Among 62 included informal caregivers, 55 (89%) responded to the follow-up questionnaires. Caregiver burden was higher among informal caregivers to patients with an adverse outcome, compared to informal caregivers to patients without an adverse outcome, caregiver burden scale score mean (+/- standard deviation) 52 (11) and 41 (13) respectively (p = 0.003). There was strong negative correlation between caregiver burden and informal caregivers' mental HRQL (r(s) -0.74, p < 0.001).

Conclusion: Informal caregivers to ICU survivors with adverse physical or psychological outcome experience a higher caregiver burden. A higher caregiver burden correlates with worse caregiver mental HRQL. ICU follow-up programs should consider screening and follow-up of informal caregivers for mental health problems.

Place, publisher, year, edition, pages
John Wiley & Sons, 2022
Keywords
anxiety, caregiver burden, critical care, depression, informal caregivers, intensive care unit, PICS, PICS-F, posttraumatic stress, psychological
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:oru:diva-95038 (URN)10.1111/aas.13988 (DOI)000703040000001 ()34582048 (PubMedID)2-s2.0-85116141399 (Scopus ID)
Funder
Swedish Research Council
Note

Funding agencies:

Region Auvergne-Rhone-Alpes

Region Bourgogne-Franche-Comte

Region Hauts-de-France

Region Nouvelle-Aquitaine

Available from: 2021-10-15 Created: 2021-10-15 Last updated: 2022-01-12Bibliographically approved
Nollet, J. L., Cajander, P., Ferris, L. F., Ramjith, J., Omari, T. I. & Savilampi, J. (2022). Pharyngo-Esophageal Modulatory Swallow Responses to Bolus Volume and Viscosity Across Time. The Laryngoscope, 132(9), 1817-1824
Open this publication in new window or tab >>Pharyngo-Esophageal Modulatory Swallow Responses to Bolus Volume and Viscosity Across Time
Show others...
2022 (English)In: The Laryngoscope, ISSN 0023-852X, E-ISSN 1531-4995, Vol. 132, no 9, p. 1817-1824Article in journal (Refereed) Published
Abstract [en]

OBJECTIVES/HYPOTHESIS: Modulation of the pharyngeal swallow to bolus volume and viscosity is important for safe swallowing and is commonly studied using high-resolution pharyngeal manometry (HRPM). Use of unidirectional pressure sensor technology may, however, introduce variability in swallow measures and a fixed bolus administration protocol may induce time and order effects. We aimed to overcome these limitations and to investigate the effect of time by repeating randomized measurements using circumferential pressure sensor technology.

STUDY DESIGN: Sub-set analysis of data from the placebo arm of a randomized, repeated measures trial.

METHODS: HRPM with impedance was recorded using a solid-state catheter with 36 circumferential pressure sensors and 18 impedance segments straddling from hypopharynx to stomach. Testing included triplicates of 5, 10, and 20 ml thin liquid and 10 ml thick liquid boluses, the order of the thin liquid boluses was randomized. The swallow challenges were repeated approximately 10 minutes after finishing the baseline measurement.

RESULTS: We included 19 healthy adults (10/9 male/female; age 24.5 ± 4.1 year). Intrabolus pressure, all upper esophageal sphincter (UES) opening and relaxation metrics, and flow timing metrics increased with larger volumes. A thicker viscosity decreased UES relaxation time, UES basal pressure, and flow timing metrics, whereas UES opening extent increased. Pre-swallow UES basal pressure and post-swallow UES contractile integral decreased over time.

CONCLUSION: Using circumferential pressure sensor technology, the effects of volume and viscosity were largely consistent with previous reports. UES contractile pressures reduced over time. The growing body of literature offers a benchmark for recognizing aberrant pharyngo-esophageal motor responses.

LEVEL OF EVIDENCE: 3 Laryngoscope, 2021.

Place, publisher, year, edition, pages
John Wiley & Sons, 2022
Keywords
Deglutition, dysphagia, high-resolution manometry, impedance, pharynx
National Category
Radiology, Nuclear Medicine and Medical Imaging
Identifiers
urn:nbn:se:oru:diva-96086 (URN)10.1002/lary.29987 (DOI)000731644300001 ()34928519 (PubMedID)2-s2.0-85121445102 (Scopus ID)
Note

Funding agency:

College of Medicine and Public Health, Flinders University

Available from: 2021-12-21 Created: 2021-12-21 Last updated: 2026-01-13Bibliographically approved
Schagatay, F., Diamant, K., Lidén, M., Edin, A., Athlin, S., Hultgren, O., . . . Cajander, S. (2022). Serum concentration of extracellular cold-inducible RNA-binding protein is associated with respiratory failure in COVID-19. Frontiers in Immunology, 13, Article ID 945603.
Open this publication in new window or tab >>Serum concentration of extracellular cold-inducible RNA-binding protein is associated with respiratory failure in COVID-19
Show others...
2022 (English)In: Frontiers in Immunology, E-ISSN 1664-3224, Vol. 13, article id 945603Article in journal (Refereed) Published
Abstract [en]

Uncontrolled release of damage-associated molecular patterns (DAMPs) is suggested to be a major trigger for the dysregulated host immune response that leads to severe COVID-19. Cold-inducible RNA-binding protein (CIRP), is a newly identified DAMP that aggravates inflammation and tissue injury, and induces respiratory failure in sepsis. Whether CIRP contributes to the pathogenesis of respiratory failure in COVID-19 has not yet been explored.

Aim: To investigate if the concentration of extracellular CIRP (eCIRP) in serum associates with respiratory failure and lung involvement by chest computed tomography (CT) in COVID-19.

Methods: Herein we report a prospective observational study of patients with COVID-19 included at two University Hospitals in Sweden between April 2020 and May 2021. Serum from hospitalized patients in Örebro (N=97) were used to assess the association between eCIRP and the level of respiratory support and its correlation with pulmonary involvement on chest CT and inflammatory biomarkers. A cohort of hospitalized and non-hospitalized patients from Umeå (N=78) was used as an external validation cohort. The severity of disease was defined according to the highest degree of respiratory support; mild disease (no oxygen), non-severe hypoxemia (conventional oxygen or high-flow nasal oxygen, HFNO <50% FiO2), and severe hypoxemia (HFNO ≥50% FiO2, mechanical ventilation). Unadjusted and adjusted linear regression was used to evaluate peak eCIRP day 0-4 in respect to severity, age, sex, Charlson comorbidity score, symptom duration, and BMI.

Results: Peak eCIRP concentrations were higher in patients with severe hypoxemia and were independently associated with the degree of respiratory support in both cohorts (Örebro; p=0.01, Umeå; p<0.01). The degree of pulmonary involvement measured by CT correlated with eCIRP, rs=0.30, p<0.01 (n=97).

Conclusion: High serum levels of eCIRP are associated with acute respiratory failure in COVID-19. Experimental studies are needed to determine if treatments targeting eCIRP reduces the risk of acute respiratory failure in COVID-19.

Place, publisher, year, edition, pages
Frontiers Media S.A., 2022
Keywords
CIRP, COVID-19, DAMPs, eCIRP, inflammation, severity
National Category
Clinical Medicine
Identifiers
urn:nbn:se:oru:diva-100684 (URN)10.3389/fimmu.2022.945603 (DOI)000840651100001 ()35967397 (PubMedID)2-s2.0-85136034592 (Scopus ID)
Funder
Region Örebro County, OLL-938628 OLL-961416Knut and Alice Wallenberg Foundation, VC-2020-0015Umeå UniversityRegion VästerbottenSwedish Heart Lung FoundationSwedish Research Council, 2020-06235
Note

Funding agency:

Centrum for klinisk forskning (CKF) Region Västmanland

Available from: 2022-08-16 Created: 2022-08-16 Last updated: 2026-03-06Bibliographically approved
Cajander, P., Omari, T. I., Cock, C., Magnuson, A., Scheinin, M. & Savilampi, J. (2021). Effects of remifentanil on pharyngeal swallowing and esophageal motility: no impact of different bolus volumes, and partial antagonism by methylnaltrexone. American Journal of Physiology - Gastrointestinal and Liver Physiology, 321(4), G367-G377
Open this publication in new window or tab >>Effects of remifentanil on pharyngeal swallowing and esophageal motility: no impact of different bolus volumes, and partial antagonism by methylnaltrexone
Show others...
2021 (English)In: American Journal of Physiology - Gastrointestinal and Liver Physiology, ISSN 0193-1857, E-ISSN 1522-1547, Vol. 321, no 4, p. G367-G377Article in journal (Refereed) Published
Abstract [en]

Background: Remifentanil impairs swallowing, and disturbed accommodation to bolus volume may be one of the underlying causes. It is not fully understood whether remifentanil-induced swallowing dysfunction is mediated by peripheral or central mechanisms.

Aims: To investigate if remifentanil-induced swallowing dysfunction is dependent on the bolus volume and whether the effect of remifentanil could be counteracted by methylnaltrexone, a peripherally acting opioid antagonist.

Methods: Nineteen healthy volunteers were included in this double-blinded, randomized, placebo-controlled, crossover study. Study participants received target-controlled remifentanil infusions and placebo infusions in a randomized order. Methylnaltrexone was administered by intravenous injection of doses of 0.3 mg/kg. Recordings of pressure and impedance data were acquired using a combined manometry and impedance solid state catheter. Data was analyzed from three series of bolus swallows, baseline, during remifentanil exposure, and 15 min after methylnaltrexone.

Results: Remifentanil induced significant effects on multiple pharyngeal and esophageal function parameters. No significant differences in remifentanil-induced swallowing dysfunction related to different bolus volumes were found. Pharyngeal effects of remifentanil were not significantly counteracted by methylnaltrexone, whereas on the distal esophageal level, effects on distension pressures were counteracted. Conclusions Changes in pharyngeal and esophageal pressure flow variables were consistent with previous results on remifentanil-induced swallowing dysfunction, and uniform across all bolus volumes. The effects of remifentanil on the pharyngeal level and on the proximal esophagus appear to be predominantly centrally mediated, whereas the effects of remifentanil on the distal esophagus may be mediated by both central and peripheral mechanisms.

NEW & NOTEWORTHY: In this randomized controlled trial, we used the "Swallow Gateway" online platform to analyze the effects of remifentanil on pharyngeal and esophageal swallowing. It is not fully understood whether remifentanil-induced swallowing dysfunction is mediated by peripheral or central mechanisms. By using methylnaltrexone, we demonstrated that effects of remifentanil on pharyngeal swallowing were predominantly centrally mediated, whereas its effects on the distal esophagus may be mediated by both central and peripheral mechanisms.

Place, publisher, year, edition, pages
HighWire Press, 2021
Keywords
Esophageal Motility, Methylnaltrexone, Pharyngeal swallowing, Remifentanil
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:oru:diva-93483 (URN)10.1152/ajpgi.00137.2021 (DOI)000701776200002 ()34261364 (PubMedID)2-s2.0-85117033838 (Scopus ID)
Note

Funding agencies:

Research Fund of the Örebro County Council

ALF research funding (Örebro University)

University of Turku

National Health and Medical Research Council of Australia

Available from: 2021-08-12 Created: 2021-08-12 Last updated: 2023-04-28Bibliographically approved
Schagatay, F., Diamant, K., Edin, A., Normark, J., Athlin, S., Hultgren, O., . . . Cajander, S. (2021). Nivån av vävnadsskademarkören cold-inducible RNA-binding protein i blod associerar till grad av respiratorisk påverkan hos sjukhusvårdade patienter med Covid-19. In: Abstract Book 2021: State Of The Art Covid-19 2021. Paper presented at State of the Art Covid-19, Digitalt, 24-25 november, 2021. Svenska Läkaresällskapet, Article ID P85.
Open this publication in new window or tab >>Nivån av vävnadsskademarkören cold-inducible RNA-binding protein i blod associerar till grad av respiratorisk påverkan hos sjukhusvårdade patienter med Covid-19
Show others...
2021 (Swedish)In: Abstract Book 2021: State Of The Art Covid-19 2021, Svenska Läkaresällskapet , 2021, article id P85Conference paper, Oral presentation with published abstract (Other academic)
Place, publisher, year, edition, pages
Svenska Läkaresällskapet, 2021
National Category
Infectious Medicine
Identifiers
urn:nbn:se:oru:diva-98916 (URN)
Conference
State of the Art Covid-19, Digitalt, 24-25 november, 2021
Available from: 2022-05-10 Created: 2022-05-10 Last updated: 2026-03-06Bibliographically approved
Milton, A., Schandl, A., Soliman, I., Joelsson-Alm, E., van den Boogaard, M., Wallin, E., . . . Sackey, P. (2020). ICU discharge screening for prediction of new-onset physical disability - a multinational cohort study. Acta Anaesthesiologica Scandinavica, 64(6), 789-797
Open this publication in new window or tab >>ICU discharge screening for prediction of new-onset physical disability - a multinational cohort study
Show others...
2020 (English)In: Acta Anaesthesiologica Scandinavica, ISSN 0001-5172, E-ISSN 1399-6576, Vol. 64, no 6, p. 789-797Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Methods to identify patients at risk for incomplete physical recovery after intensive care unit (ICU) stay are lacking. Our aim was to develop a method for prediction of new-onset physical disability at ICU discharge.

METHODS: Multinational prospective cohort study in ten general ICUs in Sweden, Denmark and the Netherlands. Adult patients with an ICU stay ≥12 hours were eligible for inclusion. Sixteen candidate predictors were analyzed with logistic regression for associations with the primary outcome; new-onset physical disability three months post-ICU, defined as a ≥10 score reduction in the Barthel Index compared to baseline.

RESULTS: Of 572 included patients, follow-up data are available on 78% of patients alive at follow-up. The incidence of new-onset physical disability was 19%. Univariable and multivariable modeling rendered one sole predictor for the outcome: physical status at ICU discharge, assessed with the five first items of the Chelsea Critical Care Physical Assessment Tool (CPAx) (odds ratio 0.87, 95% confidence interval (CI) 0.81 to 0.93), a higher score indicating a lower risk, with an area under the receiver operating characteristics curve of 0.68 (95% CI 0.61 to 0.76). Negative predictive value for a low-risk group (CPAx score >18) was 0.88, positive predictive value for a high-risk group (CPAx score ≤18) was 0.32.

CONCLUSION: The ICU discharge assessment described in this study had a moderate AUC but may be useful to rule out patients unlikely to need physical interventions post-ICU. For high-risk patients, research to determine post-ICU risk factors for an incomplete rehabilitation is mandated.

Place, publisher, year, edition, pages
Wiley-Blackwell Publishing Inc., 2020
Keywords
Activities of daily living, complications, critical care, decision support techniques, intensive care unit, rehabilitation
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:oru:diva-80169 (URN)10.1111/aas.13563 (DOI)000516886000001 ()32083323 (PubMedID)2-s2.0-85080137644 (Scopus ID)
Note

Funding Agencies:

Olle Engkvist Byggmästare Foundation  

Stockholm City Council funding for medical training and research (ALF) 

Available from: 2020-02-25 Created: 2020-02-25 Last updated: 2020-12-01Bibliographically approved
Organisations

Search in DiVA

Show all publications